A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After...
A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001
About this item
Full title
Author / Creator
Publisher
London, England: Libertas Academica
Journal title
Language
English
Formats
Publication information
Publisher
London, England: Libertas Academica
Subjects
More information
Scope and Contents
Contents
As an exceedingly recalcitrant and highly aggressive tumor type without Food and Drug Administration-approved treatment or a known cure, the prognosis of recurrent extensive stage platinum-resistant/refractory small cell lung cancer (SCLC) is worse than other types of lung cancer, and many other tumor types, given a response rate of less than 10% a...
Alternative Titles
Full title
A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6f4599bfbe04434b8699c865c8ac3cbc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6f4599bfbe04434b8699c865c8ac3cbc
Other Identifiers
ISSN
1179-5549
E-ISSN
1179-5549
DOI
10.4137/CMO.S40429
